Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma.
| Autor: | Mehta, Amy A, Kanu, Levi N, Sood-Mendiratta, Shalini, Quinones, Richard, Hawkins, Anjali, Lehrer, Richard A, Malhotra, Kiran, Papas, Robert, Hillman, David, Wilensky, Jacob T, Aref, Ahmad A, Vajaranant, Thasarat Sutabutr, Edward, Deepak P |
|---|---|
| Zdroj: | European Journal of Ophthalmology; Jan2022, Vol. 32 Issue 1, p322-326, 5p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|